☆ 4.6 Article

An immunogenic cell death-associated classification predictions are important for breast invasive carcinoma prognosis and immunotherapy

FRONTIERS IN GENETICS (2022)

Related references

Note: Only part of the references are listed.

Review Oncology

Breast cancer immune microenvironment: from pre-clinical models to clinical therapies

Brooke E. Wilson et al.

Summary: The breast cancer tumour microenvironment (BC-TME) has significant cellular and spatial heterogeneity, requiring reliable methods for quantification and characterization of its composition; immune-activating and inhibitory cells play key roles in BC-TME, with preclinical models including co-cultures, organoids, and humanized mouse models.

BREAST CANCER RESEARCH AND TREATMENT (2022)

Add to Collection

Article Pharmacology & Pharmacy

Induction of Immunogenic Cell Death by Photodynamic Therapy Mediated by Aluminum-Phthalocyanine in Nanoemulsion

Mosar Correa Rodrigues et al.

Summary: Photodynamic therapy (PDT) is a cancer treatment method that can eliminate tumors through various mechanisms, including the induction of immunogenic cell death. This study demonstrates that the concentration of the photosensitizer and the light dose can affect the immunogenicity of PDT-treated cells.

PHARMACEUTICS (2022)

Add to Collection

Review Pharmacology & Pharmacy

An Overview on Immunogenic Cell Death in Cancer Biology and Therapy

Mosar Correa Rodrigues et al.

Summary: Immunogenic cell death (ICD) is a regulated form of cell death that promotes an adaptive immune response to dying cell antigens. The release and exposure of damage-associated molecular patterns during ICD act as potent immune adjuvants. ICD induced by conventional cytotoxic agents shows promise as a potential approach for cancer immunotherapy.

PHARMACEUTICS (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Immunogenic Cell Death in Cancer Therapy

Olga S. Troitskaya et al.

Summary: Apoptosis plays a crucial role in chemotherapy-induced cell death. The conventional theory that apoptosis needs to be immunologically silent has been revised, and the concept of immunogenic cell death (ICD) has been proposed. This review describes the main features of ICD induction and its importance in anticancer therapy and cell death regulation research.

ACTA NATURAE (2022)

Add to Collection

Review Pharmacology & Pharmacy

Enhancing therapeutic performance of personalized cancer vaccine via delivery vectors

Tong Ye et al.

Summary: Personalized cancer vaccines have gained attention for their ability to overcome interindividual differences and show benefits for individual patients in the clinic. Various delivery vectors, including artificial materials, engineered microorganisms, cells and cell derivatives, have been studied to enhance the therapeutic performance of personalized cancer vaccines. These delivery vectors are utilized to improve antigen distribution and immune response strength, velocity, and duration through different delivery strategies.

ADVANCED DRUG DELIVERY REVIEWS (2021)

Add to Collection

Review Cell Biology

Natural Compounds of Marine Origin as Inducers of Immunogenic Cell Death (ICD): Potential Role for Cancer Interception and Therapy

Clementina Sansone et al.

Summary: Immunogenic cell death (ICD) plays a crucial role in stimulating immune responses by releasing DAMPs and triggering an immune reaction. ICD can develop and promote immune cell responses, enhancing the effectiveness of anticancer immune responses.

CELLS (2021)

Add to Collection

Review Cell Biology

Immune Infiltrates in Breast Cancer: Recent Updates and Clinical Implications

Maria Vittoria Dieci et al.

Summary: TILs play a significant role in BC prognosis and treatment, especially showing strong prognostic effects in triple-negative BC patients.

CELLS (2021)

Add to Collection

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Review Immunology

Cell death as part of innate immunity: Cause or consequence?

Mario Riera Romo

Summary: Regulated or programmed cell death is crucial for development, tissue organization, and immunity. Advancements in cellular and molecular research have expanded the understanding of various cell death modalities and their biochemical programs. Recent evidence points to the interconnectedness of cell death pathways and their roles in immune mechanisms.

IMMUNOLOGY (2021)

Add to Collection

Review Pharmacology & Pharmacy

Magnetic systems for cancer immunotherapy

Nicole B. Day et al.

Summary: Immunotherapy is a rapidly developing area in cancer treatment, with magnetic systems offering advantages in improving performance by increasing spatiotemporal control, reducing off-target effects, and enhancing efficacy. These systems enable various methods for programming immune responses, including magnetic hyperthermia, targeted delivery of drug carriers, structual changes in biomaterials driven by magnets, and interactions with cellular receptors using magnetic particles for promoting antitumor activity.

ACTA PHARMACEUTICA SINICA B (2021)

Add to Collection

Article Nanoscience & Nanotechnology

Immunogenic camptothesome nanovesicles comprising sphingomyelin-derived camptothecin bilayers for safe and synergistic cancer immunochemotherapy

Zhiren Wang et al.

Summary: Despite the potential of immune checkpoint blockade, it only benefits a small subset of patients. The nano-based platform for co-delivery of chemo- and immunotherapeutics shows efficient synergic antitumour activity in large, hard-to-treat tumour models.

NATURE NANOTECHNOLOGY (2021)

Add to Collection

Article Oncology

The induction of immunogenic cell death by photodynamic therapy in B16F10 cells in vitro is effected by the concentration of the photosensitizer

Jose Athayde Vasconcelos Morais et al.

Summary: Photodynamic therapy (PDT) can trigger immune responses against cancer cells by inducing immunogenic cell death (ICD). However, the induction of ICD in B16F10 melanoma cells by PDT only occurs at specific concentrations of aluminum-phthalocyanine (AlPcNE), as demonstrated in an in vivo model.

PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY (2021)

Add to Collection

Review Immunology

Immunogenic Cell Death-Based Cancer Vaccines

Ming-Zhu Jin et al.

Summary: Cancer immunotherapy has made significant progress, but is limited in immunologically cold tumors. Inducing immunogenic cell deaths (ICDs) is seen as an attractive approach to activate antitumor immunity. ICD-based cancer vaccines mimic the effect of cancer vaccines but face challenges.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Chemistry, Multidisciplinary

Smart Nanovesicle-Mediated Immunogenic Cell Death through Tumor Microenvironment Modulation for Effective Photodynamic Immunotherapy

Weijing Yang et al.

ACS NANO (2020)

Add to Collection

Article Nanoscience & Nanotechnology

Reshaping Tumor Immune Microenvironment through Acidity-Responsive Nanoparticles Featured with CRISPR/Cas9-Mediated Programmed Death-Ligand 1 Attenuation and Chemotherapeutics-Induced Immunogenic Cell Death

Kun Tu et al.

ACS APPLIED MATERIALS & INTERFACES (2020)

Add to Collection

Review Oncology

Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

Lorenzo Galluzzi et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)

Add to Collection

Review Oncology

Current Approaches for Combination Therapy of Cancer: The Role of Immunogenic Cell Death

Zahra Asadzadeh et al.

CANCERS (2020)

Add to Collection

Article Nanoscience & Nanotechnology

Tumor Microenvironment-Triggered Charge Reversal Polymetformin-Based Nanosystem Co-Delivered Doxorubicin and IL-12 Cytokine Gene for Chemo-Gene Combination Therapy on Metastatic Breast Cancer

Yue Sun et al.

ACS APPLIED MATERIALS & INTERFACES (2020)

Add to Collection

Review Oncology

Targeting immunogenic cell death in cancer

Asma Ahmed et al.

MOLECULAR ONCOLOGY (2020)

Add to Collection

Review Cell Biology

Detection of immunogenic cell death and its relevance for cancer therapy

Jitka Fucikova et al.

CELL DEATH & DISEASE (2020)

Add to Collection

Review Cell Biology

Immunogenic Cell Death and Immunotherapy of Multiple Myeloma

Alfonso Serrano-del Valle et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)

Add to Collection

Article Biochemistry & Molecular Biology

STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets

Damian Szklarczyk et al.

NUCLEIC ACIDS RESEARCH (2019)

Add to Collection

Article Oncology

Priming anti-tumor immunity by radiotherapy: Dying tumor cell-derived DAMPs trigger endothelial cell activation and recruitment of myeloid cells

Julia Krombach et al.

ONCOIMMUNOLOGY (2019)

Add to Collection

Article Chemistry, Multidisciplinary

Tumor Microenvironment-Activatable Prodrug Vesicles for Nanoenabled Cancer Chemoimmunotherapy Combining Immunogenic Cell Death Induction and CD47 Blockade

Fangyuan Zhou et al.

ADVANCED MATERIALS (2019)

Add to Collection

Article Oncology

Immunological metagene signatures derived from immunogenic cancer cell death associate with improved survival of patients with lung, breast or ovarian malignancies: A large-scale meta-analysis

Abhishek D. Garg et al.

ONCOIMMUNOLOGY (2016)

Add to Collection

Article Developmental Biology

Immunogenic cell death

Abhishek D. Garg et al.

INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2015)

Add to Collection

Article Biochemical Research Methods

Novel function discovery with GeneMANIA: a new integrated resource for gene function prediction in Escherichia coli

James Vlasblom et al.

BIOINFORMATICS (2015)

Add to Collection

Review Oncology

Immunogenic cell death and DAMPs in cancer therapy

Dmitri V. Krysko et al.

NATURE REVIEWS CANCER (2012)

Add to Collection

Article Immunology

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death

N Casares et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.